Harnessing the power of viruses to treat Huntington’s disease
Researchers design a virus to more effectively deliver gene-silencing drugs throughout the brain New therapies for disorders like Huntington’s diseaseRead more.
Through a Broader Lens: Looking at Non-Motor Symptoms in HD
Common depictions of HD emphasizing only its movement symptoms paint an incomplete picture of the real disease. HD causes bothRead more.
Looking Past the Spin: Results from a Clinical Trial of Cysteamine
In early December, Raptor Pharmaceuticals released clinical trial results evaluating a drug called cysteamine in Huntington’s disease. News headlines aboutRead more.
A recycled drug gives us new insight in to HD
Researchers have found a connection between HD and an energy-regulating protein called PPAR-delta. Giving PPAR-delta a boost with an existingRead more.
Aspirin Component Shows Promise In Treating Alzheimer’s, Parkinson’s And Huntington’s Disease
On techtimes.com Rina Marie Doctor reports that researchers from the Boyce Thompson Institute and John Hopkins University found that aspirinRead more.
Give a Toss for Huntington’s Disease
This video is an awareness campaign highlighting the impact that the toss of a “genetic coin” has had on threeRead more.
UCC Researchers focus on gene silencing approaches for HD Hope
Prof. John F. Cryan and Prof. Caitriona O’Driscoll, two researchers in University College Cork ,Ireland with very different backgrounds &Read more.
Through the eyes of a friend: changes in mood and behavior in early HD
Companions of HD gene carriers are more likely to notice psychological changes in presymptomatic HD. The family and friends ofRead more.
Research Webinar – Brain Changes in Huntington’s DiseaseRead more.